Oncology PCD Franchise Companies In India

Oncology PCD Pharma Companies in India

Top 10 Oncology Pharma Franchise Companies in India - Reports say that in India, each year nearly 6,00,000 cancer deaths occur. This has led to an increase in Global demand for cancer drugs in India. At Pharmaadda, you can find the best oncology pharma PCD Franchise Companies in India. These companies not only provide the best service for the franchise. But are also involved in manufacturing high-quality anti-cancer drugs to improve the quality of life of cancer sufferers.

Growing demographics and economies in developing countries such as China and India are expected to offer good opportunities in the oncology drugs market in Asia. The oncology/cancer drugs market is driven by the

• Growing prevalence of various types of cancer.
• The increasing demand for biological and targeted drug therapies.
• Continuous patent expiry of key cancer drugs.
• The rising impact of biosimilars.

Global Oncology/Cancer Drugs Market is expected to reach $274 billion and $484 billion by 2030, as per Allied Market Research. Indian market is about to reach $7.8 billion and $10.6 billion by 2030, as per Insights10. So, investing in Oncology Pharma Franchise Companies is profitable for an individual who is seeking an opportunity to grow their business in the pharma sector.

List of the Top 10 Oncology Pharma Franchise Companies in India

• Cytogen Pharmaceuticals India Private Limited
• Medion Biotech
• Arvincare
• Globela Pharma Pvt Ltd
• Enrico Pharmaceutical Pvt. Ltd
• AstraZeneca
• Fresenius Kabi Oncology Limited
• Pierre Fabre
• Gland Pharma Limited
• Khandelwal Laboratories Pvt. Ltd.

1. Cytogen Pharmaceuticals India Private Limited:

Cytogen Pharmaceuticals India Private Limited is a professionally managed, fastest-growing company in the oncology segment of the Indian Pharmaceutical Industry. The organization has been serving cancer patients for the last decade. The company has come up with a franchise opportunity for professionals who have contacts and good control in the oncology markets in INDIA. Cytogen Pharmaceuticals India Private Limited aims to provide the latest molecules with the best quality standards at highly competitive rates so that the majority of cancer patients can benefit.

The company is one of the leading Oncology Pharma Companies in India. Their oncology product range is as follows:

• Bingeff
• Brestozol
• C Gluta
• Chemokine
• CHEMOBORT
• Chemophos
• Chemosid
• Chemotax
• CHEMOTERE (Docetaxel)
• G.Cyte
• Gliotaz
• Neutragold
• Oxalip
• Pecitaben
• Rubicyt
• Zolenic

Contact them: Cytogen Pharmaceuticals India Pvt. Ltd., 105, Anupam Plaza, 6, Local Shopping Complex, Gazipur, Delhi-96.

2. Medion Biotech:

The company is a growing, innovative pharma company established in the year 2012. Medion involves delivering a wide range of healthcare solutions and value to its customers. They are also engaged in providing services to clients. The company is offering oncology Franchise state-wise and district-wise as well, all over India. Medion has emerged to become the premier pharmaceutical group by virtue of excellent networking links in sourcing medical drugs and providing at best competitive prices without compromising on the quality to its clients.

Medion Biotech is an Exporter of a wide range of Oncology Pharma products, which include Oxaliplatin Injection, etc. Their corporate office is situated in Delhi, and we have a sales force of more than 100 employees delivering a wide range of services to each and every corner of India. The company is ISO 9001:2015 certified. They manufacture all our products under WHO-cGMP certification. Their commitment to serving society with the message of quality, affordability, and reach has made us successful thus far. Their product list includes:

• Premetrexed Injection 100/500mg
• Docetaxel Injection 20/80/120 mg
• Leucovorin Calcium Injection IP
• Zoledronic Acid Injection 4mg
• Imatinib Mesylate Tablet IP 100/400 mg
• Bicalutamide Tablets USP 50mg
• Mediotax 100mg
• Epirubicin Hydrocloride 10/50mg Injection
• Voriconazole 200 mg Tablet
• Temozolomide Capsule 20/100/250 mg
• Bortezomib Injection 2mg
• Thalidomide Capsule 100mg U.S.P
• Anastrozol Tablets IP 1mg

3. Arvincare:

Arvincare holds expertise in offering a wide range of Oncology Medicines. This assortment includes Anticancer Medicines. These medicines are processed under the guidance of medical experts utilizing superior quality ingredients that are sourced from the reliable and certified vendors of the market. These medicines are also tested on various parameters to ensure their effectiveness.  They have very good coordination & understanding with WHO units.

The company personnel make sure to keep a safe & sound environment in these premises by operating in proximity to each other. Owing to the vast manufacturing facility and sound financial and ethical code of conduct, they can serve a vast client base across the world. They export their products to Northern Europe, East Asia, the Middle East, Southeast Asia, the Indian Subcontinent, and North America. Their oncology pharma product range is as follows:

• Rubicin-10 with composition of Doxorubicin 10 mg
• Rubicin-50 with composition of Doxorubicin 50 mg
• Cisplatin- 150 with composition of Carboplatin 150 mg
• Cisplatin- 450 with composition Carboplatin 450 mg
• Ocaxel-20 with composition Docetaxel 20 mg
• Ocaxel-80 with composition Docetaxel 80 mg
• Pubs in-10 with composition Epirubicin 10 mg
• Pubs-50 with composition Epirubicin 50 mg
• Taxel- 30 with a composition of 30 mg
• Taxel- 100 with composition 100 mg
• Satin-50 with a composition of Cisplatin 50 mg
• Taxel- 260 with composition 260 mg
• Satin-10 with composition Cisplatin 10 mg
• Altin-50 with composition Oxaliplatin 50 mg, etc.

Contact them - SCO-62, Sector -12A Panchkula - 134109 Haryana, India

4. Globela Pharma Pvt Ltd.:

Globela Pharma was incorporated in the year 1998 and started manufacturing APIs and Intermediates. The company is an established ISO, FDCA – INDIA, WHO cGMP-accredited pharmaceutical formulation manufacturing company. Globela Pharma strives to help patients to fight against cancer. The company is committed to developing breakthrough innovations to extend help and improve the lives of people with cancer worldwide using its completely dedicated Oncology facility.

They are one of the leading and Topmost Oncology Pharma Franchise Companies in India. They are committed to offering standard quality products at a cost-effective price to reach out to a maximum number of patients and help them by providing easy access to medicines to fight against cancer. Their oncology pharma product range is as follows:

• ANAGLOB
• PROSTAGLOBGLOSULFAN
• BUSULPHAN TABLETS IP 2 MG
• CYCLOGLOB
• SPORGLOB
• DASAGLOB 50
• ERLOGLOB 150
• GLOMUSTIN
• ETOGLOB 100
• ZEFTIGLO
• GLOUREA 500
• GLOMATINIB 400
• GLOCARBAZIN
• SUNITINIB
• TAMGLOB
• GLOTEMOZ - 250 etc.

Contact them: Plot No. 357-358, Road No. 3, G.I.D.C Sachin, Surat, Gujarat, India. PIN: 394 230.

5. Enrico Pharmaceutical Pvt. Ltd.:

Enrico Pharmaceuticals is a leading pharmaceutical and healthcare products company. A multi-crore entity, with a WHO-cGMP and ISO 9001:2008 certified state-of-the-art manufacturing facility. ENRICO Pharmaceutical is a supplier and manufacturer for importers/distributors, governments, and hospitals with the products they need for their markets. ENRICO’s domestic oncology division deals with haemato-oncology and solid tumor products.

These product portfolios consist of molecules that are of decisive therapeutic importance in cancers of the blood, liver, kidney, lung, brain, breast, ovary, etc. They acknowledge the fact that the real growth of a business depends primarily on the kind of professional relationships it develops and retains with its customers as well as partners. Therefore, their franchise partners are approved through extreme transparency on the basis of the area as well as districts and are free to operate within their allocated localities without any or minimal intervention from the company.

Their oncology pharma products range is as follows:

• Temozolomide Capsules 100 mg
• Temozolomide Capsules 250 mg
• Capecitabine Tablets 150 mg
• Capecitabine Tablets 500 mg
• Imatinib Tablets 100 mg
• Imatinib Tablets 400 mg
• Gefitinib Tablets 250 mg
• Anastrozole Tablets 1 mg
• Letrozole Tablets 2.5 mg
• Tamoxifen Citrate etc.

Contact them - A.O: A2/9, Site-IV, Industrial Area, Sahibabad, DELHI-NCR-201010

6. AstraZeneca (Best Anti-Cancer drug franchise companies):

At AstraZeneca, the team is committed to advancing the science of oncology to deliver life-changing medicines to patients most in need. With a combination-focused pipeline that exploits the power of four scientific platforms to help address unmet clinical needs in a host of cancers, we are motivated by a dedication to scientific discovery and collaboration that will one day help eliminate cancer as a cause of death.

Their robust pipeline includes investigational therapies in varying stages of clinical development, from recently approved products to earlier-stage molecules in clinical trials. AstraZeneca medicines are approved in individual countries for specific uses, and the information they provide for patients is governed by local regulations. Their product list includes:

• Arimidex
• Calquence
• Casodex, Cosudex
• Faslodex
• Imfinzi
• Iressa
• Lynparza
• Tagrisso
• Zoladex etc.

Contact them - Corporate & Registered Office Block N1, 12th Floor, Manyata Embassy Business Park, Rachenahalli, Outer Ring Road, 560045, Bangalore

7. Fresenius Kabi Oncology Limited:

Fresenius Kabi Oncology Limited develops, manufactures, and markets anti-cancer products for critically and chronically ill patients. As a part of the globally reputed Fresenius Healthcare Group, it plays a pivotal role in patient care, both within and outside hospitals, to efficaciously carry forward its mission of “caring for life”.  Fresenius Kabi Oncology Limited provides high-quality and cost-effective pharmaceutical products to markets worldwide.

• Breast Cancer
• Lung Cancer
• Ovarian Cancer
• Head & Neck Cancer
• Prostate Cancer
• Hematological Malignancies
• Gastrointestinal Malignancies
• Brain Tumors
• Supportive Care

Contact them - Echelon Institutional Area, Plot No. 11, Sector - 32, Gurgaon, PIN code - 122001, Haryana, India

8. Pierre Fabre (Top Anticancer API Manufacturer India):

The company has made oncology research one of its priorities, with programs focusing in particular on biotechnologies, immunotherapy, and targeted biotherapies. Their manufacturing plants for oncology products are certified by the American, European, and Japanese pharmaceutical agencies.

The company's business activity is focused on research, development, manufacturing, and marketing of cosmetics, prescription medicines, and family health products. Pierre Fabre is best known for its vinorelbine (Navelbine), an anticancer drug of the vinca alkaloid class. They also developed vinflunine, a fluorinated vinca alkaloid derivative available in Australia for "advanced or metastatic transitional cell carcinoma of the urothelial tract after the failure of a prior platinum-containing regimen."

The company works in fields where the medical expectations are extremely high:

• solid tumors (breast, lung, colon, ovarian, bladder, and ENT cancers)
• onco-hematology (leukemia, myeloma, bone marrow transplants)
• and onco-dermatology

Contact them - URMI ESTATE Building, Tower A, 11th Floor, 95, Ganpatrao Kadam Marg, Lower Parel, MUMBAI, INDIA 400013

9.  Gland Pharma Limited:

Gland Pharma Limited was founded in the year 1978. The company is the first in India to set up a state-of-the-art Pre-Filled Syringes (PFS) facility at Hyderabad, as well as the first liquid injectable facility in India to be accepted by USFDA. In addition, they have a USFDA-accepted Oncology facility at Visakhapatnam. They are one of the leading Pharma Franchise companies for the Oncology Range. The company serves the pharmaceutical needs of diverse markets worldwide by developing niche products through our strong in-house R&D expertise in:

• Synthesis of complex drug molecules such as Low Molecular Weight Heparins (LMWHs) and anti-cancer drugs
• Developing complex injectables such as lyophilized products, high-potency drugs, and long-acting suspensions

Contact them - 6-3-865/1/2, Greenland Apartments Ameerpet, Hyderabad - 500016, India

10. Khandelwal Laboratories Pvt. Ltd. (Top Oncology PCD Company):

KLab is a pioneer in bringing oncology products to India and has a dedicated formulation and API facility focused on developing countries. KLab also provides contract manufacturing for more than 10 companies. These products are such that KLab can get fast-track FDA approval in India without clinical trials.  It has one of the widest ranges of Oncology formulations, which are manufactured at a KLab-owned WHO-GMP-approved facility at Thane, Mumbai.

Their product range caters to the following therapeutic areas:

• BLEOCIN
• BORTEZOMIB
• DOXORUBICIN
• IMATINATE
• RIBOREA
• XOLNIC
• CAPXCEL
• DOCETAXEL
• ERLOTAZ
• GEFTIN etc.

Contact them - 79/87 D.LADPATH MUMBAI 400 033, INDIA

Conclusion:

Every year, there is a 20% increase in the oncology market in India, which is a great scope for growth in your business. Companies, through their quality medicines and formulations and other services, make their place in the list of the Top 10 Oncology Pharma Franchise Companies in India at Pharmaadda.

FAQs About Top 10 Oncology Pharma Franchise Companies in India -

Q1. Are Oncology products in high demand?

Ans. India is experiencing a rise in cancer cases. Thus, the demand for oncology products is increasing. Hence, in today's times, oncology products are in high demand.

Q2. How much is the Global Oncology Market expected to rise by 2030?

Ans. The Global Oncology Market is expected to increase to between $274 billion and $484 billion by the year 2030.

Q3. What are the main reasons to invest in Oncology Pharma Franchise Companies in India?

Ans. Investing in Oncology Pharma Franchise Companies in India is beneficial in terms of profit for individuals who seek opportunities to grow their business in the pharma industry due to the rising demand for oncology medicines in India and the increased requirement for high-quality anti-cancer drugs.